PHARMASAMBRE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMASAMBRE
Largest movements
- Receivables within one year -€61,173
down €61,173 (-16.3%), from €376,146 to €314,973
of which Other amounts receivable: -€60,472
- Deferred charges and accrued income +€14,970
up €14,970 (+449.3%), from €3,332 to €18,302
- Cash +€11,502
up €11,502 (+5.0%), from €230,317 to €241,819
mainly Net result for the year (+€122,705) and Receivables within one year (+€61,173)
- Profit (loss) carried forward -€42,295
down €42,295 (-7.6%), from €554,426 to €512,131
- Other debts +€14,868
up €14,868 (+9.9%), from €150,132 to €165,000
- Debts after one year -€12,887
down €12,887 (-6.6%), from €194,430 to €181,543
- Write-downs +€30,267
new in 2025: €30,267
- Gross operating margin -€11,112
down €11,112 (-3.0%), from €365,162 to €354,051
- Taxes -€10,505
down €10,505 (-34.6%), from €30,360 to €19,856
- Staff costs +€6,884
up €6,884 (+4.5%), from €153,072 to €159,956
- Financial charges -€6,472
down €6,472 (-69.5%), from €9,310 to €2,838
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,023,962 | €977,337 | -€46,625 | -4.6% |
| Fixed assets | 21/28 | €208,086 | €201,606 | -€6,479 | -3.1% |
| Tangible fixed assets | 22/27 | €208,086 | €201,606 | -€6,479 | -3.1% |
| Land and buildings | 22 | €202,245 | €188,845 | -€13,400 | -6.6% |
| Plant, machinery and equipment | 23 | €4,453 | €1,039 | -€3,413 | -76.7% |
| Furniture and vehicles | 24 | €1,388 | €1,722 | +€334 | +24.1% |
| Assets under construction and advance payments | 27 | - | €10,000 | +€10,000 | |
| Current assets | 29/58 | €815,876 | €775,731 | -€40,145 | -4.9% |
| Stocks and contracts in progress | 3 | €206,081 | €200,636 | -€5,445 | -2.6% |
| Stocks | 30/36 | €206,081 | €200,636 | -€5,445 | -2.6% |
| Amounts receivable within one year | 40/41 | €376,146 | €314,973 | -€61,173 | -16.3% |
| Trade receivables | 40 | €177,514 | €176,813 | -€700 | -0.4% |
| Other amounts receivable | 41 | €198,632 | €138,160 | -€60,472 | -30.4% |
| Cash at bank and in hand | 54/58 | €230,317 | €241,819 | +€11,502 | +5.0% |
| Deferred charges and accrued income | 490/1 | €3,332 | €18,302 | +€14,970 | +449.3% |
| Total equity and liabilities | 10/49 | €1,023,962 | €977,337 | -€46,625 | -4.6% |
| Equity | 10/15 | €574,886 | €532,591 | -€42,295 | -7.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €554,426 | €512,131 | -€42,295 | -7.6% |
| Amounts payable | 17/49 | €449,076 | €444,746 | -€4,329 | -1.0% |
| Amounts payable after more than one year | 17 | €194,430 | €181,543 | -€12,887 | -6.6% |
| Financial debts | 170/4 | €194,430 | €181,543 | -€12,887 | -6.6% |
| Amounts payable within one year | 42/48 | €254,646 | €263,162 | +€8,516 | +3.3% |
| Current portion of amounts payable after more than one year | 42 | €12,754 | €12,887 | +€133 | +1.0% |
| Trade debts | 44 | €64,106 | €61,751 | -€2,356 | -3.7% |
| Suppliers | 440/4 | €64,106 | €61,751 | -€2,356 | -3.7% |
| Taxes, remuneration and social security | 45 | €27,653 | €23,524 | -€4,129 | -14.9% |
| Taxes | 450/3 | €4,402 | - | -€4,402 | |
| Remuneration and social security | 454/9 | €23,251 | €23,524 | +€273 | +1.2% |
| Other amounts payable | 47/48 | €150,132 | €165,000 | +€14,868 | +9.9% |
| Accrued charges and deferred income | 492/3 | - | €42 | +€42 | |
| Remuneration, social security and pensions | 62 | €153,072 | €159,956 | +€6,884 | +4.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,136 | €17,718 | -€417 | -2.3% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €30,267 | +€30,267 | |
| Other operating charges | 640/8 | €222 | €750 | +€529 | +238.4% |
| Gross operating margin | 9900 | €365,162 | €354,051 | -€11,112 | -3.0% |
| Operating profit (loss) | 9901 | €193,733 | €145,359 | -€48,373 | -25.0% |
| Financial income | 75/76B | - | €39 | +€39 | |
| Recurring financial income | 75 | - | €39 | +€39 | |
| Financial charges | 65/66B | €9,310 | €2,838 | -€6,472 | -69.5% |
| Recurring financial charges | 65 | €9,310 | €2,838 | -€6,472 | -69.5% |
| Profit (loss) for the period before taxes | 9903 | €184,422 | €142,560 | -€41,862 | -22.7% |
| Income taxes | 67/77 | €30,360 | €19,856 | -€10,505 | -34.6% |
| Profit (loss) for the period | 9904 | €154,062 | €122,705 | -€31,357 | -20.4% |
| Profit (loss) for the period to be appropriated | 9905 | €154,062 | €122,705 | -€31,357 | -20.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.